NO874691L - Middel for appetittregulering eller sovemiddel. - Google Patents

Middel for appetittregulering eller sovemiddel.

Info

Publication number
NO874691L
NO874691L NO874691A NO874691A NO874691L NO 874691 L NO874691 L NO 874691L NO 874691 A NO874691 A NO 874691A NO 874691 A NO874691 A NO 874691A NO 874691 L NO874691 L NO 874691L
Authority
NO
Norway
Prior art keywords
sleeping agent
agent
appearance regulation
regulation
sleeping
Prior art date
Application number
NO874691A
Other languages
English (en)
Other versions
NO874691D0 (no
Inventor
Charlotte Erlanson-Albertsson
Original Assignee
Draco Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE8604953A external-priority patent/SE8604953D0/xx
Priority claimed from SE8702274A external-priority patent/SE8702274D0/xx
Application filed by Draco Ab filed Critical Draco Ab
Publication of NO874691D0 publication Critical patent/NO874691D0/no
Publication of NO874691L publication Critical patent/NO874691L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Obesity (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Middel for appetlttregulerlng eller et sovemiddel son består av aktiverIngspeptldet 1 prokollpase, bestående av peptldsekvensen. hvori a) X er Ala og T er Gly, eller b) X er Val og T Asp. eller. et derivat derav.
NO874691A 1986-11-20 1987-11-11 Middel for appetittregulering eller sovemiddel. NO874691L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE8604953A SE8604953D0 (sv) 1986-11-20 1986-11-20 Aptitreglerande medel eller somnmedel
SE8702274A SE8702274D0 (sv) 1987-06-01 1987-06-01 Aptitreglerande medel eller somnmedel ii

Publications (2)

Publication Number Publication Date
NO874691D0 NO874691D0 (no) 1987-11-11
NO874691L true NO874691L (no) 1988-05-24

Family

ID=26659581

Family Applications (1)

Application Number Title Priority Date Filing Date
NO874691A NO874691L (no) 1986-11-20 1987-11-11 Middel for appetittregulering eller sovemiddel.

Country Status (13)

Country Link
US (1) US5494894A (no)
EP (1) EP0269595B1 (no)
JP (1) JP2575159B2 (no)
AU (1) AU608783B2 (no)
CA (1) CA1302878C (no)
DE (1) DE3786530T2 (no)
DK (1) DK583687A (no)
ES (1) ES2056838T3 (no)
FI (1) FI875129A (no)
IE (1) IE60452B1 (no)
NO (1) NO874691L (no)
NZ (1) NZ222480A (no)
PH (1) PH25586A (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE64356B1 (en) * 1986-07-28 1995-07-26 Bioscience Int Inc Diagnosis severity prediction and monitoring of disease by immunoassay of free activation peptides of pancreatic zymogens
DK583687A (da) * 1986-11-20 1988-05-21 Draco Ab Middel til regulering af appetit eller sovemiddel
SE9100284D0 (sv) * 1991-01-30 1991-01-30 Astra Ab Novel peptide
US6686444B2 (en) 1996-08-22 2004-02-03 Children's Medical Center Corporation Osteopontin derived chemotactic peptides and methods of use
FR2754827B1 (fr) * 1996-10-17 1998-12-24 Biocem Lipases pancreatiques et/ou colipases recombinantes et polypeptides dervies produits par les plantes, leurs procedes d'obtention et leurs utilisations
US6180494B1 (en) * 1999-03-11 2001-01-30 Micron Technology, Inc. Integrated circuitry, methods of fabricating integrated circuitry, methods of forming local interconnects, and methods of forming conductive lines
SE0302253D0 (sv) * 2003-08-21 2003-08-21 Forskarpatent I Syd Ab Lipase-colipase inhibitor
WO2007070563A2 (en) * 2005-12-13 2007-06-21 Harkness Pharmaceuticals, Inc. Stable solid forms of enterostatin
EP1973558A4 (en) * 2005-12-13 2009-12-23 Harkness Pharmaceuticals Inc METHODS OF TREATING OBESITY WITH ENTEROSTATIN
US20070149442A1 (en) * 2005-12-13 2007-06-28 Byron Rubin Non-hygroscopic compositions of enterostatin
AU2007272954A1 (en) * 2006-07-11 2008-01-17 Harkness Pharmaceuticals, Inc. Methods of treating obesity using satiety factors
WO2009033815A2 (en) * 2007-09-11 2009-03-19 Mondobiotech Laboratories Ag Use of the peptide combination ala-pro-gly-pro-arg with cecropin a as a therapeutic agent

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4491578A (en) * 1982-06-14 1985-01-01 Peikin Steven R Method of stimulating satiety in mammals
US4948723A (en) * 1987-01-16 1990-08-14 Bioscience International, Inc. Method of diagnosis and severity-assessment of pancreatic disease
IE64356B1 (en) * 1986-07-28 1995-07-26 Bioscience Int Inc Diagnosis severity prediction and monitoring of disease by immunoassay of free activation peptides of pancreatic zymogens
DK583687A (da) * 1986-11-20 1988-05-21 Draco Ab Middel til regulering af appetit eller sovemiddel

Also Published As

Publication number Publication date
NZ222480A (en) 1991-07-26
CA1302878C (en) 1992-06-09
EP0269595B1 (en) 1993-07-14
ES2056838T3 (es) 1994-10-16
AU8091487A (en) 1988-05-26
AU608783B2 (en) 1991-04-18
DE3786530T2 (de) 1993-10-28
EP0269595A3 (en) 1990-06-13
FI875129A (fi) 1988-05-21
JP2575159B2 (ja) 1997-01-22
US5494894A (en) 1996-02-27
DK583687D0 (da) 1987-11-06
IE873124L (en) 1988-05-20
NO874691D0 (no) 1987-11-11
DE3786530D1 (de) 1993-08-19
EP0269595A2 (en) 1988-06-01
FI875129A0 (fi) 1987-11-19
DK583687A (da) 1988-05-21
PH25586A (en) 1991-08-08
JPS63211235A (ja) 1988-09-02
IE60452B1 (en) 1994-07-13

Similar Documents

Publication Publication Date Title
NO873699L (no) Polypeptid som er egnet til dempning, behandling og diagnostisering av autoimmune lidelser saasom leddbetennelser.
NL300066I2 (nl) Behandeling van zwaarlijvigheid.
GB1534822A (en) Dental chairs or like patient supporting devices
NO874691L (no) Middel for appetittregulering eller sovemiddel.
NO893769D0 (no) Fremgangsmaate for behandling av naturgass.
DE3882593T2 (de) Polypeptid und dessen Herstellung.
IT8621171A0 (it) Preparazione di fluoroetileni e clorofluoroetileni da clorofluoroetani.
DE69230508D1 (de) Azeotropische Zusammensetzung von 1,1,2,2,3,3,4,4-Octafluorbutan und Methanol, n-Propanol oder Aceton
NO910720D0 (no) Vektorer og forbindelser for ekspresjon av zymogene former av humant protein c.
NO881322L (no) Fremgangsmaate og anlegg for behandling av returnert boreslam.
IT8621011A0 (it) Specchio decorativo e procedimento per la sua realizzazione.
EP0336368A3 (en) N2-(1-carboxy-3-phenylpropyl)-l-lysine derivative and process of producing lysinopril using the compound
FI904708A0 (fi) Anordning foer kontrollerad foerbraenning av laettantaendlig vaete-luft-blandning i en kaernteknisk anlaeggning.
NO893962D0 (no) Fremgangsmaate og innretning til oppdeling av fiskefileteri stykker.
DE69024400T2 (de) Dem menschlichen Calpastatin ähnliches Polypeptid
IT1226386B (it) Procedimento di preparazione di morniflumato e analoghi.
NO890061D0 (no) Fremstilling og anvendelse av gallosilikataromatiseringskatalysator.
PL288140A1 (en) Polypeptide, vaccine, expression vector, method of immunizing human organisms, method of obtaining polypeptide and method of obtaining such vaccine and expression vector
ZA894502B (en) Treatment of skins and hides
NO179400C (no) Katalysatorsystem og fremgangsmåte for fremstilling av 1,2-diklorethan
NO914919L (no) Nikkelbasert superlegering og anvendelse av denne
DE68918639T2 (de) Färbehilfsmittelzusammensetzung und Färbeverfahren.
NO892506L (no) Kloning og ekspresjon av human vevsfaktor.
NO891485D0 (no) Fremgangsmaate til fremstilling av 22 kd-sgh-protein og lineaer genevektor.
AU3773489A (en) Treatment of skins and hides